Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î] µ¿¹°ÀÇ ÀÎüÀǾàǰ »ç¿ë, ÇØ¿Ü´Â ¾î¶³±î
³»   ¿ë

µ¿¹°ÀÇ ÀÎüÀǾàǰ »ç¿ë, ÇØ¿Ü´Â ¾î¶³±î

µ¿¹°ÀÇ ÀÎüÀǾàǰ »ç¿ë¿¡ ´ëÇÑ ±¹³»¿Ü ¹ý·É ºñ±³ <1>


º» °í¿¡¼­´Â Áö³­ 2020³â 2¿ù ¹ß°£µÈ ¡®ÀǾàǰÁ¤Ã¥¿¬±¸¡¯ 14±Ç 2È£ [ƯÁý] ÁÖÁ¦¿´´ø µ¿¹°ÀǾàǰ °ü¸® ÇöȲ°ú °ü·ÃÇØ ½Ç·È´ø <µ¿¹°ÀÇ ÀÎüÀǾàǰ »ç¿ë¿¡ ´ëÇÑ ±¹³»¿Ü ¹ý·É ºñ±³> ¿ø°í¸¦ ¿øÀúÀÚÀÇ ½ÂÀÎÀ» ¹Þ¾Æ, ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ® ÇмúÁö¸éÀ» ÅëÇØ Àç¼Ò°³ÇϰíÀÚ ÇÑ´Ù. ¡®ÀǾàǰÁ¤Ã¥¿¬±¸¡¯´Â ÀǾàǰ °³¹ß, »ý»ê, À¯Åë ¹× »ç¿ë°ú °ü·ÃµÈ Á¤Ã¥Àû À̽´¸¦ ±íÀÌ ÀÖ°Ô ¿¬±¸?ºÐ¼®ÇØ ÇÕ¸®ÀûÀΠÁ¤Ã¥À» Á¦½ÃÇϰíÀÚ 2006³â Ã¢°£µÈ ÀÌ·¡ ¿¬ 2ȸ ²ÙÁØÈ÷ ¹ßÇàµÇ°í Àִ Á¤±â°£Ç๰ÀÌ´Ù. [ÆíÁýÀÚ ÁÖ]


¥°. µé¾î°¡¸ç
2013³â 8¿ù 2ÀÏ µ¿¹°¿ëÀǾàǰÀÌ ¿À¡¤³²¿ëµÅ µ¿¹° ¹× Ãà»ê¹°¿¡ ÀÜ·ùÇϰųª Ç×»ýÁ¦ ³»¼º±ÕÀÇ ÃâÇö µîÀ» ¿¹¹æÇϱâ À§ÇÑ ¸ñÀûÀ¸·Î ¼öÀÇ»çó¹æÁ¦°¡ ½ÃÇàµÆ´Ù. 

ÀÌ Á¦µµÀÇ ½Ç½Ã·Î Ãà»ê³ó°¡¿Í µ¿¹° ¼ÒÀ¯ÀÚ µîÀº Ã³¹æ ´ë»ó µ¿¹°ÀǾàǰÀÇ »ç¿ëÀÌ ÇÊ¿äÇÒ °æ¿ì¿¡´Â ¹Ýµå½Ã µ¿¹°º´¿ø ¼öÀÇ»çÀÇ Áø·á ÈÄ¿¡ Á¶Á¦¹Þ°Å³ª Ã³¹æÀüÀ» ¹ß±Þ¹Þ¾Æ µ¿¹°¾àǰ ÆÇ¸Å¾÷¼Ò(µµ¸Å»ó ¶Ç´Â µ¿¹°¾à±¹)¿¡¼­ ÇØ´ç ¾àǰÀ» ±¸¸ÅÇØ¾ß ÇÑ´Ù.

ºñ·Ï ¼öÀÇ»çó¹æÁ¦ÀÇ ¸ñÀûÀÌ ÁַΠÃà»êµ¿¹°¿¡°Ô »ç¿ëµÇ´Â µ¿¹°ÀǾàǰÀÇ ÀÜ·ù³ª Ç×»ýÁ¦ ³»¼ºÀ» ¿¹¹æÇϱâ À§ÇÑ °ÍÀ̾úÀ¸³ª ¹Ý·Áµ¿¹° º¸È£ÀÚ¿Í ¾à»çµéÀº ¼öÀÇ»çó¹æÁ¦ÀÇ ½Ç½Ã·Î ¹Ý·Áµ¿¹°¿¡ ´ëÇѠó¹æÀüµµ ¹ß±ÞµÇ¸®¶ó ±â´ëÇß´Ù. 

±×·¯³ª ±â´ë¿Í´Â ´Þ¸® ¼öÀÇ»ç Ã³¹æÀº Ãà»êµ¿¹°(½Ä¿ëµ¿¹°)¿¡ ÇÑÇØ¼­ ¹ß±ÞµÆ°í, ¹Ý·Áµ¿¹°¿¡ ´ëÇØ¼­´Â °ÅÀÇ ¹ß±ÞµÇÁö ¾Ê¾Ò´Ù. ±× ÀÌÀ¯´Â ÇöÀç ¾à»ç¹ýÀ̳ª ¼öÀÇ»ç¹ý¿¡ ¹Ý·Áµ¿¹°¿¡°Ô ¸¹ÀÌ »ç¿ëµÇ°í Àִ ÀÎüÀǾàǰ¿¡ ´ëÇÑ ¹ýÀû ±Ù°ÅÁ¶Ç×ÀÌ ¾ø±â ¶§¹®ÀÌ´Ù.

ÇöÀç ¾à»ç¹ý¿¡¼­ ¾à»ç´Â ÀÇ»ç¿Í Ä¡°úÀÇ»çÀǠó¹æ¿¡ ÀÇÇØ¼­¸¸ ÀÎü¿ë Àü¹®ÀǾàǰÀ» Á¶Á¦ ¶Ç´Â ÆÇ¸ÅÇÒ ¼ö ÀÖµµ·Ï ±ÔÁ¤Çϰí ÀÖ´Ù. 

ÀÌ Á¶Ç×À¸·Î ÀÎÇØ 2013³â 8¿ù ¼öÀÇ»ç Ã³¹æÁ¦°¡ ½ÃÇàµÆÁö¸¸ µ¿¹°º´¿ø¿¡¼­ ¹Ý·Áµ¿¹° º¸È£ÀÚ¿¡°Ô ¹ßÇàµÇ´Â Ã³¹æÀüÀº °ÅÀÇ ¾ø´Â »óȲÀÌ´Ù. 

´ëºÎºÐÀÇ ¹Ý·Áµ¿¹° Ã³¹æ(70% Á¤µµ)ÀÌ ÀÎüÀǾàǰÀ» Æ÷ÇÔÇϰí ÀÖ°í ¾à»ç¹ý 23Á¶(ÀǾàǰ Á¶Á¦)¿Í 50Á¶(ÀǾàǰ ÆÇ¸Å)ÀǠó¹æÀÚÀÇ ¹üÀ§¿¡ ¼öÀǻ簡 ºüÁ® Àֱ⠶§¹®¿¡ ÇöÀç ¾à»ç¹ý»óÀ¸·Î ¼öÀǻ簡 ÀÎü Àü¹®ÀǾàǰ Ã³¹æÀ» Á¶Á¦ÇÒ ¼ö Àִ ±Ù°Å°¡ ºÎÁ·Çϱ⠶§¹®ÀÌ´Ù. 

¶Ç ¼öÀÇ»çÀÇ ÀÎüÀǾàǰ »ç¿ë¿¡ ´ëÇØ¼­´Â µ¿¹°À» Áø·áÇÒ ¸ñÀûÀ¸·Î ÀÎüÀǾàǰÀ» ¾à±¹¿¡¼­ ±¸ÀÔÇÒ ¼ö ÀÖ°í ¼öºÒ´ëÀåÀ» ºñÄ¡ÇØ¾ß ÇѴٴ °£´ÜÇÑ ¹ýÀû Á¶Ç׸¸ À־ Á¾·ùÀÇ ¾àÀ» ¾î´À Á¤µµ »ç¿ëÇϰí ÀÖ´ÂÁö ÆÄ¾ÇÀÌ ºÒ°¡´ÉÇÏ´Ù. 

¶Ç ¼öÀǻ翡 ´ëÇÑ °ü¸®´Â ³ó¸²Ãà»ê½ÄǰºÎ¿¡¼­ °ü¸®Çϰí ÀÎüÀǾàǰÀº º¸°Çº¹ÁöºÎ¿¡¼­ °ü¸®ÇØ ¼öÀǻ簡 »ç¿ëÇϴ ÀÎüÀǾàǰ¿¡ ´ëÇØ °ü¸®ºÎó ¶ÇÇÑ ¸ðÈ£ÇÑ »óÅÂÀÌ´Ù.

ÀÌ·¯ÇÑ »óȲ¿¡¼­ ¼öÀÇ»çÀÇ µ¿¹°¿¡ ´ëÇÑ ÀÎüÀǾàǰ »ç¿ë ¹× Ã³¹æ¿¡ ´ëÇÑ ¹ý·É°ú ÀÎüÀǾàǰÀÌ Æ÷ÇԵȠµ¿¹° Ã³¹æÀü¿¡ ´ëÇØ ¾à»ç°¡ Á¶Á¦ÇÒ ¼ö Àִ ±Ù°Å¸¦ ±¹³» ¹ý·É¿¡¼­ Ã£¾Æº¸°íÀÚ Çß°í µ¿¹°¿¡ ´ëÇÑ ÀÎüÀǾàǰ Ã³¹æ°ú Á¶Á¦¿¡ ´ëÇØ Çؿܠ¹ý·ÉÀº ¾î¶»°Ô ±ÔÁ¤Çϰí ÀÖ´ÂÁö¸¦ Á¶»çÇØ ±¹³» ¹ý·É°úÀÇ ºñ±³¸¦ ÅëÇØ ½Ã»çÁ¡À» Ã£°íÀÚ Çß´Ù.


¥±. µ¿¹°ÀÇ ÀÎü¿ëÀǾàǰ »ç¿ë ±¹°¡º° ¹ý·ü ¹× ±ÔÁ¤ °ËÅä
±¹°¡ ¼±Á¤Àº µ¿¹°¿¡ »ç¿ëÇϴ ÀǾàǰ¿¡ ´ëÇÑ ¹ý·ÉÀÌ Àß Á¤ºñµÅ Àִ ±¹°¡·Î ¹Ì±¹°ú ¿µ±¹, ´ºÁú·£µå¸¦ ¼±ÅÃÇÏ°í ¹ý·É°ú ¹®È­°¡ ºñ½ÁÇÑ ÀϺ»À» °ñ¶ú´Ù. 

±¹³» ¹ý·ÉÀº ±¹°¡¹ý·É¼¾Å͸¦ ÅëÇØ ÇöÇà ¾à»ç¹ý°ú ¼öÀÇ»ç¹ý, µ¿¹°¿ëÀǾàǰ Ãë±Þ±ÔÄ¢, ¾à»ç¹ý ½ÃÇà±ÔÄ¢À» Á¶»çÇß°í ¿¬Çõ¹ý·ÉÀ» ÅëÇØ ¾à»ç¹ý°ú, ¼öÀÇ»ç¹ý, ¾à»ç¹ý ½ÃÇà±ÔÄ¢ÀÇ °³Á¤¿¡ µû¸¥ º¯°æ ³»¿ëÀ» ¾Ë¾ÆºÃ´Ù. 

ÇØ¿Ü¹ý·ÉÀº °¢±¹ÀÇ ¹ý·É À¥»çÀÌÆ®¿Í °¢±¹ Á¤ºÎÀÇ Áöħ°ú °¡À̵堵îÀ» Á¶»çÇß´Ù<Ç¥1>. <´ÙÀ½È£¿¡ °è¼Ó>




¹ÚÁö¿µ. °æ±âµµ¾à»çȸ µ¿¹°¾àǰÀ§¿øÀå


[±â»çÃâó] https://www.kpanews.co.kr/academy/show.asp?page=1&search_cate=8&idx=324



 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
92 [¸ÞµðÆÄ³ª´º½º]'Äڷγª19 ´ëÀÀ¡¤ÅëÇÕµ¹º½' ´Ù·é ÀǾàǰÁ¤Ã¥¿¬±¸ ¹ß°£  ±è¼±Èñ 2021-01-19 4
91 [¾à»ç°ø·Ð] ¾à±¹ °ÅÁ¡ Àڻ쿹¹æ»ç¾÷, »ý¸íÁöÅ´ÀÌ ¿ªÇÒ 'ÅåÅå'  ±è¼±Èñ 2021-01-19 3
90 [µ¥Àϸ®ÆÊ] ÀϺ»¾à±¹ÀÇ ÁøÈ­¡¦Ä«µå·Î 'Áߺ¹Åõ¾à¡¤³²Àº ¾à °ü¸®±îÁö'  ±è¼±Èñ 2021-01-19 6
89 [´ëÇѾà»çÀú³Î] ¼¼ÀÌÇÁ¾à±¹¡¤¹æ¹®¾à·á µî Ȱµ¿ Áö¼Ó Áõ°¡  ÀÌÁö¿¬ 2021-01-19 3
88 [´ëÇѾà»çÀú³Î] ¾à±¹ ó¹æÁýÁßµµ º¯È­¿Í ¾à±¹¾à»çÀÇ »çȸÀû ¿ªÇÒ Ãß±¸ ÀÌÁö¿¬ 2021-01-13 45
87 [´ëÇѾà»çÀú³Î] ÀåÁ¡Àº Ű¿ì°í ´ÜÁ¡Àº ¾ø¾Ö´Â ±³À°¹æ¹ýÀº? ÀÌÁö¿¬ 2021-01-06 77
86 [´ëÇѾà»çÀú³Î] 'Àڱ⠹ݿµ ¾ç½Ä' ÅëÇØ ¾à±¹ Àü¹®°¡ ±âÁØ ÆÄ¾Ç ÀÌÁö¿¬ 2020-12-29 80
85 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-22 92
84 ¹Ì±¹¡¤¿µ±¹ ¾à»ç, ¿Â¶óÀÎÀ¸·Î ¾î¶»°Ô °øºÎÇϳª ±è¼±Èñ 2020-12-16 95
83 ÀǾàǰÁ¤Ã¥¿¬ "¿Â¶óÀÎ ¿¬¼ö±³À°¿¡ CPD µµÀÔÇØ¾ß" ±è¼±Èñ 2020-12-16 89
82 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-16 77
81 [´ëÇѾà»çÀú³Î] Áö¿ª ¿©°Ç ¸ÂÃá 'Ä¡¸Å¾È½É¸¶À»'+'Ä¡¸Å¾È½É¾à±¹' ¿î¿µ ÀÌÁö¿¬ 2020-12-08 98
80 [´ëÇѾà»çÀú³Î] È£ÁÖ ¾à±¹ÀÇ Ä¡¸Å Äɾî Àü·«Àº? ÀÌÁö¿¬ 2020-12-01 109
79 [¾à»ç°ø·Ð] Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦ '¿Ö ¾à»ç´Â ºüÁ³À»±î'¡¦¿Ü±¹Àº ¾î¶»°Ô? ±è¼±Èñ 2020-11-25 127
78 [µ¥Àϸ®ÆÊ] ³â µÚ Ä¡¸ÅÀα¸ 100¸¸ ½Ã´ë¡¦¾à±¹ ¿ªÇÒÀ» ã¾Æ¶ó ±è¼±Èñ 2020-11-25 129

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»